Using artificial intelligence-based models to predict the risk of mucormycosis among COVID-19 survivors: An experience from a public hospital in India.

Introduction: India reported a severe public health challenge not only due to the COVID-19 outbreak but also the increasing number of associated mucormycosis cases since 2021.This study aimed at developing artificial intelligence based models to predict the risk of mucormycosis among the patients at...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Infection Vol. 84; no. 3; pp. 351 - 355
Autores principales: Syed-Abdul, Shabbir, Babu, A. Shoban, Bellamkonda, Raja Shekhar, Itumalla, Ramaiah, Acharyulu, GVRK, Krishnamurthy, Surya, Ramana, Y. Venkat Santosh, Mogilicharla, Naresh, Malwade, Shwetambara, Li, Yu-Chuan, Li, Yu-Chuan Jack
Formato: Journal Article
Publicado: W B Saunders Mar2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155490073&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 155490073
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01634453
        8IL
      jtl: Journal of Infection
      issn: 01634453
      maglogo: N
    pubinfo:
      dt: Mar2022
      vid: 84
      iid: 3
      pid: 1351
      pub: W B Saunders
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        155490073
        155490073
        NLM34953910
        10.1016/j.jinf.2021.12.016
        NLM34953910
        155490073
      ppf: 351
      ppct: 4
      formats:
      tig:
        atl: Using artificial intelligence-based models to predict the risk of mucormycosis among COVID-19 survivors: An experience from a public hospital in India.
      aug:
        au:
          Syed-Abdul, Shabbir
          Babu, A. Shoban
          Bellamkonda, Raja Shekhar
          Itumalla, Ramaiah
          Acharyulu, GVRK
          Krishnamurthy, Surya
          Ramana, Y. Venkat Santosh
          Mogilicharla, Naresh
          Malwade, Shwetambara
          Li, Yu-Chuan
          Li, Yu-Chuan Jack
        affil: Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, 5F., No. 172-1, Sec. 2, Keelung Rd. Da'an, Taipei 106, Taiwan
      sug:
      ab: Introduction: India reported a severe public health challenge not only due to the COVID-19 outbreak but also the increasing number of associated mucormycosis cases since 2021.This study aimed at developing artificial intelligence based models to predict the risk of mucormycosis among the patients at the time of discharge from hospital.Methods: The dataset included of 1229 COVID-19 positive patients, and additional 214 inpatients, COVID-19 positive as well as infected with mucormycosis. We used logistic regression, decision tree and random forest and the extreme gradient boosting algorithm. All our models were evaluated with 5-fold validation to derive a reliable estimate of the model error.Results: The logistic regression, XGBoost and random forest performed equally well with AUROC 95.0, 94.0, and 94.0 respectively. The best accuracy and precision (PPV) were 0.91 ± 0.026 and 0.67 ± 0.0526, respectively achieved by XGBoost, followed by logistic regression. This study also determined top five variables namely obesity, anosmia, de novo diabetes, myalgia, and nasal discharge, which showed positive impact towards the risk of mucormycosis.Conclusion: The developed model has the potential to predict the patients at high risk and thus, consequently initiating preventive care or aiding in early detection of mucormycosis infection. Thus, this study, holds potential for early treatment and better management of patients suffering from COVID-19 associated mucormycosis.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N